Navigation Links
Full Results of AIDS Vaccine Trial Confirm Modest Benefit
Date:10/20/2009

ared to 74 who were given placebos, the Times said.

Although the 31 percent reduction in rates of infection was modest, Col. Jerome H. Kim, a doctor who manages the U.S. Army's HIV vaccine program, called the finding statistically significant. And, he added, it's "first evidence that we could have a safe and effective preventive vaccine," AP reported.

The Thais chosen for the study were a cross-section of that country's young adult population, not just high-risk groups such as intravenous drug users or sex workers, Kim added.

According to the study, there was a non-significant trend that suggested that low-risk individuals gained more protective benefit from the vaccine than those at higher risk, such as intravenous drug users who shared needles, or people who had contact with prostitutes.

"Perhaps the requirements for protection against transmission in low-risk, heterosexual persons are considerably different or less stringent than those in high-risk subjects," Dr. Raphael Dolin, of Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, wrote Tuesday in an accompanying editorial in the journal.

Dorin also noted that although the trial lasted three years, "there is a suggestion that more of the effect might have occurred during the first year." More study needs to be done to determine if, in fact, the shot's benefits fade with time, he said.

The chief usefulness of the ALVAC-AIDSVAX vaccine will probably be what it can teach infectious-disease researchers about what is happening in the immune system when a person is even somewhat protected against HIV.

More information

To learn more about HIV and AIDS, visit the U.S. Centers for Disease Control and Prevention.



SOURCES: Oct. 20, 2009, New England Journal of Medicine; Associated Press; The N
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine news :

1. Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conference Provide Insight for Future Research
2. Cardiome Pharma Corp. Announces Final Results of Tender Offer
3. Omnicell to Release Third Quarter 2009 Earnings Results on October 22
4. Smart Balance to Host Webcast/Conference Call on 2009 Third-Quarter Results
5. Herley Reports Fourth Quarter and Year-End Results
6. ResMed Announces Conference Call and Webcast to Discuss First Quarter 2010 Results
7. ViroPharma to Release 2009 Third Quarter Financial Results on October 28, 2009
8. BioMed Realty Trust to Report 2009 Third Quarter Results
9. OnBase Equals Bottom Line Results for the 2009 RealSolutions Winners
10. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Third Quarter 2009 Results Webcast
11. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2009 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... (PRWEB) June 19, 2013 The ... program is this Friday, June 21 at midnight ... ongoing programs and innovative people who’ve raised the ... information, visit http://www.minonline.com/ima . , Any consumer ... magazine title is eligible to enter. Additionally, advertising ...
(Date:6/19/2013)... Utah (PRWEB) June 19, 2013 Today, ... Wisconsin Health Insurance Exchange . Zane Benefits, which provides ... benefits, is the leader in defined contribution ... to Zane Benefits’ website, as part of the Affordable ... small businesses will become available through new state health ...
(Date:6/19/2013)... The Journal of Parasitology – Although ... software, it creates questions of ethics. For scientific publications, ... already published case shows, scientific publications need clear guidelines ... Journal of Parasitology features a commentary on ... article published in the Journal of the New York ...
(Date:6/19/2013)... Pa. (June 19, 2013) The results of three ... of Neurosurgery , official journal of the ... published by Lippincott Williams & Wilkins , a ... study indicates that continuous "machine learning" using artificial neural ... in patients with advanced brain cancers. Another study in ...
(Date:6/19/2013)... early April, senior leaders from medical, law enforcement, military, ... one question: how can first responders improve survival after ... results of this discussion are now available in " ... ," a concept paper published in the June issue ... Acute Care Surgery , official publication of the ...
Breaking Medicine News(10 mins):Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Hartford consensus aims to improve survival after mass shootings 2
... are supporting WaterAid to deliver the most wished for Christmas present in ... ... Bendalls are appealing to social media groups, the Australian blog community and ... donate and download a e-Christmas Card , with a personalized message. ...
... scientists and the news media have evolved tremendously over ... improve communications with both the media and the lay ... commentary appears this month in a major scientific journal. ... and pharmacology at Wake Forest University School of Medicine, ...
... white women to have reconstruction after mastectomy , , MONDAY, ... women are more likely to have immediate breast reconstruction ... , This is also true for more educated women ... black women and those who live in predominantly black ...
... found little link between drinking and malignancies , , MONDAY, ... your chances of developing cancer after age 65, new ... lack of physical activity were among the usual suspects ... to the Duke University study. , The findings are ...
... nanoparticles and polymer carriers as potential new techniques ... and blindness in the United States, according to ... Research Institute Conference. , The report ( http://www.iovs.org/cgi/content/full/49/11/4712 ... for ocular drug delivery to the posterior segment ...
... LAKE CITY Nov. 17, 2008 Researchers at the ... trial that uses a patient,s own stem cells to treat ... Repair Cell Treatment of Patients with Dilated Cardiomyopathy (IMPACT-DCM) study ... (CRC) and their ability to improve heart function. , Patients ...
Cached Medicine News:Health News:Urgent Request for Water 2Health News:Award-winning researcher says relationships with news media, public are critical 2Health News:Award-winning researcher says relationships with news media, public are critical 3Health News:Wealthy More Likely to Have Breast Reconstruction 2Health News:Stay Upbeat, Exercise to Help Prevent Cancer in Old Age 2Health News:Conference report highlights new research into drug delivery to treat eye disease 2Health News:U of U researchers to use patient's own stem cells to treat heart failure 2
(Date:6/19/2013)... SUNNYVALE, Calif. , June 19, 2013 ... today announced that The New England Journal of ... a Phase 1b/2 study evaluating the investigational oral Bruton,s ... chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ... patients with relapsed/refractory CLL or SLL, even in patients ...
(Date:6/19/2013)... CHICAGO , June 19, 2013 The Physician-Patient ... reduce alarm fatigue. The need to urgently address ... in its Sentinel Event Alert #50 , "Medical device alarm ... Alert database, between January 2008 and June 2012, there were ... 80 resulted in death (82%) , 13 resulted in ...
(Date:6/19/2013)...   Voices Against Brain Cancer (VABC), a ... cancer, today announced that it has awarded Tocagen Inc. ... investigation of Toca 511 & Toca FC in patients ... (Grade 3 or Grade 4).  Tocagen is a privately ... with an initial focus on brain cancer. ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 2Three Lessons Learned to Reduce Alarm Fatigue and Improve Alarm Management and Patient Safety in Hospitals 3Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 2Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 3
Post-Surgical compression garments...
... Albumin Cobalt Binding (ACB®) Test is a ... Albumin (IMA®) by measuring the cobalt binding ... sample. First identified in the early 1990s, ... in contact with ischemic tissue in the ...
... Albumin Cobalt Binding (ACB®) Test is a ... Albumin (IMA®) by measuring the cobalt binding ... sample. First identified in the early 1990s, ... in contact with ischemic tissue in the ...
... menu includes kits that quantitatively measure two ... (a). An elevated serum or plasma homocysteine ... and independent risk factor for cardiovascular disease. ... have associated elevated levels of Lp(a) with ...
Medicine Products: